MedPath
FDA Approval

Nipent

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Hospira, Inc.
DUNS: 141588017
Effective Date
December 21, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Pentostatin(2 mg in 1 mL)

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Hospira Australia Pty Ltd

Hospira, Inc.

758967652

Zydus Hospira Oncology Private Limited

Hospira, Inc.

676190889

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nipent

Product Details

NDC Product Code
0409-0801
Application Number
NDA020122
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
December 20, 2023
Code: 395575MZO7Class: ACTIBQuantity: 2 mg in 1 mL
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath